Caladrius Biosciences to Present at Upcoming November Conferences
Oct 27, 2016 11:30 am UTC| Business
BASKING RIDGE, N.J., Oct. 27, 2016 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and manufacturing services provider (PCT)...
Provision Holding Announces Fiscal Year Results
Oct 27, 2016 11:30 am UTC| Business
CHATSWORTH, Calif., Oct. 27, 2016 -- Provision Holding, Inc. (OTCQB:PVHO) announced today financial results for the fiscal year ended June 30, 2016 which reflected the company’s sales and installations of its 3D Savings...
Valero Energy Partners LP Reports Third Quarter 2016 Results
Oct 27, 2016 11:11 am UTC| Business
Reported net income attributable to partners of $52 million and EBITDA attributable to the Partnership of $66 million.Reported net cash provided by operating activities of $62 million and distributable cash flow of...
Bionik Laboratories Provides Corporate Update and Business Outlook
Oct 27, 2016 11:06 am UTC| Business
Robotics upper and lower body development and commercial product line focused on stroke rehabilitation and mobility solutionsDevelopment and commercialization strategy designed to provide robotic rehabilitation product...
DuPont Fabros Technology, Inc. Announces Purchase of Shell Building in the Greater Toronto Area
Oct 27, 2016 11:06 am UTC| Business
WASHINGTON, Oct. 27, 2016 -- DuPont Fabros Technology, Inc. (NYSE:DFT), a leading owner, developer, operator and manager of enterprise-class, carrier-neutral, large multi-tenant wholesale data centers announced today...
Oct 27, 2016 11:05 am UTC| Business
SALT LAKE CITY, Oct. 27, 2016 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced it will present two new studies at the American Society of...
Agios to Webcast Conference Call of Third Quarter 2016 Financial Results on November 3, 2016
Oct 27, 2016 11:05 am UTC| Business
CAMBRIDGE, Mass., Oct. 27, 2016 -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced that the company will host a conference...